{"nct_id":"NCT02409368","title":"An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2015-04-29","start_date_type":"ACTUAL","primary_completion_date":"2018-03-07","primary_completion_date_type":"ACTUAL","completion_date":"2021-08-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}